News & Events
MAR / 2022
Global Coordinating Center for Late Phase Covid-19 TrialsSymyoo was designated as a global coordinating center to run late phase multinational clinical trials for Covid-19 medication development. The trials are conducted widely across Korea and European countrie. Symyoo understands well that the trial operations should be very specific to the risk and complexity of each region/country where the trials are conducted.
NOV / 2021
SYMYOO America, Inc. EstablishedEstablished Symyoo America, Inc. in order to provide global trial consulting services for the Korean pharmaceutical, biotechnology and life-science companies wishing to enter the global market.
NOV / 2019
Korea CDISC Coordinating Committee (K3C), CDISC/SDTM Industry PartnerSymyoo participated in Korea CDISC Coordinating Committee (K3C) and achieved CDISC/SCDM industry partnership, which is granted to a company having comprehensive data management capability for clinical research.
MAR / 2019
IWRS, RBM Integration into SYMYOO EDC, SYNeRA™Symyoo EDC system, SYNeRA™, expanded its functionalities by integrating new modules, including IWRS (Interactive Web-based Randomization System), IP Accountability (Investigational Product Tracking and Management System), and RBM (Risk-Based Monitoring System). Symyoo IWRS can handle various randomization algorithms from simple purmuted block randomization to very complex covariate adaptive randomization (biased coin, minimum sufficient).
NOV / 2018
150+ Trials and 30th Oncology Trial on SYMYOO's 9th AnniversaryConducted more than 150 clinical studies, including 30 oncology trials over 9 years since its foundation in 2009. Symyoo had been coordinating and collaborating with various
FEB / 2016
Introducing SYMYOO EDC, SYNeRA™Launched Symyoo EDC system, SYNeRA™ for clinical research data collection and management. Symyoo SMART TRIALS research center continues to develop and expand SYNeRA™ functionalities into a web-based Comprehensive Clinical Trial Management System.
OCT / 2015
Partnership with KU Anam HospitalBegan research collaboration with Global Clinical Trial Center of Anam Hospital, Korea University Medical Center
SEP / 2014
Korea CRO Association MemberQualified for full membership in Korea Clinical Trial CRO Association.
JUL / 2014
SMART TRIALS Research CenterEstablished SMART TRIALS center to research and faciliate new IT technologies for tomorrow's medicines. Symyoo reorganized data management and biostatistics team to offer broader data management services.
SEP / 2013
Partnership with Inje Clinical Trial CenterPartnership contract with Clinical Trial Center of Baek University Hospital, Inje University
NOV / 2012
First Global Phase III Trial as Coordinating CenterSymyoo was designated as the Korea coordinating center to run a multinational phase III clinical trial, which was the first NIH/NINDS study (ATACH 2: Antihypertensive Treatment of Acute Cerebral Hemorrhage II) operated in South Korea. The sponsor audit was also conducted to evaluate trial conduct and compliance with the protocol and SOPs without finding any issue when the trial was successfully completed in 2015.
MAR / 2010
First Phase III Pivotal TrialSymyoo expanded its business into a full scope CRO and began to operate a first phase III trial for permature ejaculation study.
NOV / 2009
SYMYOO FoundedDongjin Yoo, CEO & MD, founded a CRO to help K-Bio industry's clinical development after his successful journey as a CEO and medical director of many global pharmaceuticals and bio startups.
© 2009-2022 SYMYOO Co., Ltd. All rights reserved.